Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells
Authors:
- Jin-Jian LuJin-Jian Lu
- Jia-Jie GuoJGJia-Jie Guo
- Ming-Qing HuangMHMing-Qing Huang
- Li GanLGLi Gan
- Xiu-Ping ChenXCXiu-Ping Chen
- Yi-Tao WangYWYi-Tao Wang
- 1 March 2013
- journal article
- Published by Springer Nature in Pharmacological Reports
- Vol. 65 (2) , 453-459
Abstract
Dihydroartemisinin (DHA) exhibits potent anti-malarial and anti-cancer activities. This study aimed to investigate the anti-proliferative effects of a combination of DHA and doxorubicin (DOX) on human breast cancer cells. MTT assay and the combination index (CI) were used to show the anti-proliferative effects and calculate the synergism potential, respectively. Flow cytometry assay was used to detect apoptosis and the intracellular accumulation of DOX. JC-1 staining was used to determine the mitochondrial membrane potential. Western blot analysis was used to detect the protein expression of some apoptosis-related molecules. Asynergistic anti-proliferative effect was found, and the enhanced anti-cancer activity was observed to be accompanied by the prompt onset of apoptosis in MCF-7 cells. The combinative treatment remarkably decreased the mitochondrial membrane potential and activated caspase cascades more than the mono-treatment. Pretreatment with DHA also did not influence the accumulation of DOX in MCF-7 cells. This study presented a new opportunity to enhance the effectiveness of future treatment regimens of breast cancer using DOX.Keywords
This publication has 20 references indexed in Scilit:
- Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell lineMolecular and Cellular Biochemistry, 2011
- The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cellsInvestigational New Drugs, 2010
- Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCα/Raf/MAPKs and NF-κB/AP-1-dependent mechanismsBiochemical Pharmacology, 2010
- Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cellsCancer Biology & Therapy, 2010
- Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of ActionClinical Cancer Research, 2008
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Antimalarial dihydroartemisinin also inhibits angiogenesisCancer Chemotherapy and Pharmacology, 2004
- Molecular Modes of Action of Artesunate in Tumor Cell LinesMolecular Pharmacology, 2003
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984
- Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive InhibitorsEuropean Journal of Biochemistry, 1981